Description

11H-Pyrido[2,1-B]Quinazolin-11-One, 6,7,8,9-Tetrahydro-6-[(4-Hydroxy-3,5-Dimethoxyphenyl)Methylene]-2,3,4-Trimethoxy-, (6E)- is a complex heterocyclic compound featuring a fused pyrido-quinazolinone core with multiple methoxy and hydroxy substituents. This molecular architecture makes it a valuable advanced pharmaceutical intermediate for the synthesis of novel active ingredients. It is primarily utilized by research organizations and pharmaceutical manufacturers engaged in drug discovery and development, particularly for targeting complex biological pathways.

Application

• Pharmaceutical Intermediate: Serves as a key building block in the synthesis of potential drug candidates, especially in oncology and neurology research.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies to develop new therapeutic agents with optimized efficacy.
• Biochemical Tool Compound: Employed in vitro and in vivo to study specific enzyme inhibition or receptor modulation.
• Organic Synthesis Reference Standard: Acts as a high-purity standard for analytical method development and validation in QC laboratories.
• Academic Research: Utilized in university and institutional labs for exploring novel heterocyclic chemistry and reaction methodologies.
• Contract Research & Manufacturing (CRO/CMO): Supplied to service organizations supporting the pharmaceutical development pipeline.

Basic Information

Product Name	11H-Pyrido[2,1-B]Quinazolin-11-One, 6,7,8,9-Tetrahydro-6-[(4-Hydroxy-3,5-Dimethoxyphenyl)Methylene]-2,3,4-Trimethoxy-, (6E)-
CAS No.	876303-89-8
Molecular Formula	C24H25NO7
Molecular Weight	439.46 g/mol
Synonyms	(6E)-6-[(4-Hydroxy-3,5-dimethoxyphenyl)methylene]-2,3,4-trimethoxy-6,7,8,9-tetrahydro-11H-pyrido[2,1-b]quinazolin-11-one; 6-[(4-Hydroxy-3,5-dimethoxyphenyl)methylene]-2,3,4-trimethoxy-6,7,8,9-tetrahydro-11H-pyrido[2,1-b]quinazolin-11-one; 876303-89-8; Pyrido[2,1-b]quinazolin-11-one derivative; Tetrahydro-pyrido-quinazolinone derivative
EINECS	Contact for details

Quality Control

Our production of this high-purity intermediate adheres to stringent quality protocols. Every batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the exacting standards required for pharmaceutical research. Certificates of Analysis (COA) with detailed chromatographic data are provided to guarantee traceability and consistency for your critical development work.

Storage

Preserve in a tightly closed container, protected from light. Store at controlled room temperature (15-25°C) in a dry, well-ventilated area. This compound is light-sensitive (store away from light) and should be handled under inert atmosphere to prevent degradation.

Specification

Item	Specification
Appearance	Yellow to light brown powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.